Bioxytran Inc
OTC:BIXT
Bioxytran Inc
OTC:BIXT
Price:
0.038
USD
-6.63%
Market Closed
Market Cap:
$3.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Bioxytran Inc
OTC:BIXT
|
US |
|
Zoo Digital Group PLC
F:2ZD
|
UK |
|
J
|
Jinhua Chunguang Technology Co Ltd
SSE:603657
|
CN |
Balance Sheet
Balance Sheet Decomposition
Bioxytran Inc
Bioxytran Inc
Balance Sheet Decomposition is not available for
Bioxytran Inc
Bioxytran Inc
Balance Sheet
Bioxytran Inc
Bioxytran Inc
Currency: USD
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
+33%
|
0
+175%
|
0
+95%
|
0
-40%
|
0
-56%
|
0
-51%
|
0
-7%
|
1
+1 304%
|
0
-95%
|
0
+503%
|
0
+49%
|
0
-63%
|
0
+211%
|
0
-62%
|
0
-1%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
3
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+700%
|
0
-13%
|
0
-64%
|
0
+40%
|
0
+157%
|
0
+86%
|
0
-25%
|
0
+36%
|
0
-46%
|
0
+43%
|
1
+289%
|
3
+210%
|
3
-9%
|
3
+7%
|
3
-17%
|
2
-25%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
1
|
5
|
8
|
10
|
11
|
13
|
14
|
14
|
0
|
2
|
5
|
9
|
11
|
16
|
19
|
|
| Additional Paid In Capital |
0
|
0
|
1
|
5
|
8
|
10
|
11
|
13
|
14
|
15
|
0
|
1
|
2
|
6
|
8
|
13
|
17
|
|
| Total Equity |
0
N/A
|
0
-400%
|
0
+40%
|
0
N/A
|
0
+119%
|
0
-77%
|
0
N/A
|
0
+12%
|
0
-49%
|
1
N/A
|
0
N/A
|
1
-255%
|
3
-254%
|
3
+2%
|
3
+2%
|
2
+10%
|
2
+26%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
+33%
|
0
+175%
|
0
+95%
|
0
-40%
|
0
-56%
|
0
-51%
|
0
-7%
|
1
+1 304%
|
0
-95%
|
0
+503%
|
0
+49%
|
0
-63%
|
0
+211%
|
0
-62%
|
0
-1%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
85
|
86
|
97
|
111
|
123
|
145
|
87
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
43
|
|
Switch to:
Switch to:
See Also
Discover More
